CERC News

Cerecor, which is developing a novel adjunct therapy for major depressive disorder, raised $26 million by offering 4.0 million shares at $6.50, within the range of $6 to $7. In its prior amendment, Cerecor had disclosed that it would be offering 4.23 million units. Each unit will consist of one common share, one Class A warrant immediately exercisable for one share at...read more

Home, home below the range: all five deals this week priced below the range.  There were eleven companies on the IPO calendar this week, but only five were able to price, and each of those priced at least 19% below their...read more

Cerecor, which is developing a novel adjunct therapy for major depressive disorder, revised terms for its IPO on Thursday. The Baltimore, MD-based company had originally planned to raise $27 million by offering 4.23 million shares at a price range of $6 to $7. At the midpoint of the range, it would have commanded a market value of $58 million. In its latest amendment,...read more

The last week of September has 11 IPOs on the calendar – more IPOs than all of August 2015.  Out of 134 offerings so far in 2015, 61 have been health care companies. Next week, 7 out of the 11 IPOs on the calendar are health care. A large foodservice distributor and three...read more